Stage 3 infant formula is a specialized formula designed for toddlers aged 12-24 months. It differs from Stage 2 formula in its nutritional composition to meet the evolving nutritional needs of growing toddlers. Stage 3 formula typically contains higher levels of protein and fat to support muscle growth and activity. Additionally, it may also contain probiotics and prebiotics to promote gut health.
The global Stage 3 Infant Formula market was valued at US$ 32070 million in 2023 and is anticipated to reach US$ 50430 million by 2030, witnessing a CAGR of 6.6% during the forecast period 2024-2030.
North American market for Stage 3 Infant Formula is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Stage 3 Infant Formula is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Stage 3 Infant Formula include Mead Johnson, Nestle, Danone, Abbott, FrieslandCampina, Heinz, Bellamy, Topfer, HiPP, Perrigo, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Stage 3 Infant Formula, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stage 3 Infant Formula.
The Stage 3 Infant Formula market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Stage 3 Infant Formula market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stage 3 Infant Formula manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mead Johnson
Nestle
Danone
Abbott
FrieslandCampina
Heinz
Bellamy
Topfer
HiPP
Perrigo
Arla
Holle
Meiji
Biostime
China Feihe
Junlebao Dairy
Ausnutria Dairy
Yili Group
Synutra
Beingmate
Yashili
Bright Dairy
by Type
Conventional
Organic
by Application
Online Sales
Offline Sales
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Stage 3 Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Stage 3 Infant Formula in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Stage 3 Infant Formula Market Overview
1.1 Product Definition
1.2 Stage 3 Infant Formula by Type
1.2.1 Global Stage 3 Infant Formula Market Value Comparison by Type (2024-2030)
1.2.2 Conventional
1.2.3 Organic
1.3 Stage 3 Infant Formula by Application
1.3.1 Global Stage 3 Infant Formula Market Value by Application (2024-2030)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Stage 3 Infant Formula Market Size Estimates and Forecasts
1.4.1 Global Stage 3 Infant Formula Revenue 2019-2030
1.4.2 Global Stage 3 Infant Formula Sales 2019-2030
1.4.3 Global Stage 3 Infant Formula Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Stage 3 Infant Formula Market Competition by Manufacturers
2.1 Global Stage 3 Infant Formula Sales Market Share by Manufacturers (2019-2024)
2.2 Global Stage 3 Infant Formula Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Stage 3 Infant Formula Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Stage 3 Infant Formula, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Stage 3 Infant Formula, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Stage 3 Infant Formula, Product Type & Application
2.7 Global Key Manufacturers of Stage 3 Infant Formula, Date of Enter into This Industry
2.8 Global Stage 3 Infant Formula Market Competitive Situation and Trends
2.8.1 Global Stage 3 Infant Formula Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Stage 3 Infant Formula Players Market Share by Revenue
2.8.3 Global Stage 3 Infant Formula Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Stage 3 Infant Formula Market Scenario by Region
3.1 Global Stage 3 Infant Formula Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Stage 3 Infant Formula Sales by Region: 2019-2030
3.2.1 Global Stage 3 Infant Formula Sales by Region: 2019-2024
3.2.2 Global Stage 3 Infant Formula Sales by Region: 2025-2030
3.3 Global Stage 3 Infant Formula Revenue by Region: 2019-2030
3.3.1 Global Stage 3 Infant Formula Revenue by Region: 2019-2024
3.3.2 Global Stage 3 Infant Formula Revenue by Region: 2025-2030
3.4 North America Stage 3 Infant Formula Market Facts & Figures by Country
3.4.1 North America Stage 3 Infant Formula Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Stage 3 Infant Formula Sales by Country (2019-2030)
3.4.3 North America Stage 3 Infant Formula Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Stage 3 Infant Formula Market Facts & Figures by Country
3.5.1 Europe Stage 3 Infant Formula Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Stage 3 Infant Formula Sales by Country (2019-2030)
3.5.3 Europe Stage 3 Infant Formula Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Stage 3 Infant Formula Market Facts & Figures by Region
3.6.1 Asia Pacific Stage 3 Infant Formula Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Stage 3 Infant Formula Sales by Region (2019-2030)
3.6.3 Asia Pacific Stage 3 Infant Formula Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Stage 3 Infant Formula Market Facts & Figures by Country
3.7.1 Latin America Stage 3 Infant Formula Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Stage 3 Infant Formula Sales by Country (2019-2030)
3.7.3 Latin America Stage 3 Infant Formula Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Stage 3 Infant Formula Market Facts & Figures by Country
3.8.1 Middle East and Africa Stage 3 Infant Formula Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Stage 3 Infant Formula Sales by Country (2019-2030)
3.8.3 Middle East and Africa Stage 3 Infant Formula Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Stage 3 Infant Formula Sales by Type (2019-2030)
4.1.1 Global Stage 3 Infant Formula Sales by Type (2019-2024)
4.1.2 Global Stage 3 Infant Formula Sales by Type (2025-2030)
4.1.3 Global Stage 3 Infant Formula Sales Market Share by Type (2019-2030)
4.2 Global Stage 3 Infant Formula Revenue by Type (2019-2030)
4.2.1 Global Stage 3 Infant Formula Revenue by Type (2019-2024)
4.2.2 Global Stage 3 Infant Formula Revenue by Type (2025-2030)
4.2.3 Global Stage 3 Infant Formula Revenue Market Share by Type (2019-2030)
4.3 Global Stage 3 Infant Formula Price by Type (2019-2030)
5 Segment by Application
5.1 Global Stage 3 Infant Formula Sales by Application (2019-2030)
5.1.1 Global Stage 3 Infant Formula Sales by Application (2019-2024)
5.1.2 Global Stage 3 Infant Formula Sales by Application (2025-2030)
5.1.3 Global Stage 3 Infant Formula Sales Market Share by Application (2019-2030)
5.2 Global Stage 3 Infant Formula Revenue by Application (2019-2030)
5.2.1 Global Stage 3 Infant Formula Revenue by Application (2019-2024)
5.2.2 Global Stage 3 Infant Formula Revenue by Application (2025-2030)
5.2.3 Global Stage 3 Infant Formula Revenue Market Share by Application (2019-2030)
5.3 Global Stage 3 Infant Formula Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mead Johnson
6.1.1 Mead Johnson Company Information
6.1.2 Mead Johnson Description and Business Overview
6.1.3 Mead Johnson Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mead Johnson Stage 3 Infant Formula Product Portfolio
6.1.5 Mead Johnson Recent Developments/Updates
6.2 Nestle
6.2.1 Nestle Company Information
6.2.2 Nestle Description and Business Overview
6.2.3 Nestle Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Nestle Stage 3 Infant Formula Product Portfolio
6.2.5 Nestle Recent Developments/Updates
6.3 Danone
6.3.1 Danone Company Information
6.3.2 Danone Description and Business Overview
6.3.3 Danone Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Danone Stage 3 Infant Formula Product Portfolio
6.3.5 Danone Recent Developments/Updates
6.4 Abbott
6.4.1 Abbott Company Information
6.4.2 Abbott Description and Business Overview
6.4.3 Abbott Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Stage 3 Infant Formula Product Portfolio
6.4.5 Abbott Recent Developments/Updates
6.5 FrieslandCampina
6.5.1 FrieslandCampina Company Information
6.5.2 FrieslandCampina Description and Business Overview
6.5.3 FrieslandCampina Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.5.4 FrieslandCampina Stage 3 Infant Formula Product Portfolio
6.5.5 FrieslandCampina Recent Developments/Updates
6.6 Heinz
6.6.1 Heinz Company Information
6.6.2 Heinz Description and Business Overview
6.6.3 Heinz Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Heinz Stage 3 Infant Formula Product Portfolio
6.6.5 Heinz Recent Developments/Updates
6.7 Bellamy
6.7.1 Bellamy Company Information
6.7.2 Bellamy Description and Business Overview
6.7.3 Bellamy Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Bellamy Stage 3 Infant Formula Product Portfolio
6.7.5 Bellamy Recent Developments/Updates
6.8 Topfer
6.8.1 Topfer Company Information
6.8.2 Topfer Description and Business Overview
6.8.3 Topfer Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Topfer Stage 3 Infant Formula Product Portfolio
6.8.5 Topfer Recent Developments/Updates
6.9 HiPP
6.9.1 HiPP Company Information
6.9.2 HiPP Description and Business Overview
6.9.3 HiPP Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.9.4 HiPP Stage 3 Infant Formula Product Portfolio
6.9.5 HiPP Recent Developments/Updates
6.10 Perrigo
6.10.1 Perrigo Company Information
6.10.2 Perrigo Description and Business Overview
6.10.3 Perrigo Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Perrigo Stage 3 Infant Formula Product Portfolio
6.10.5 Perrigo Recent Developments/Updates
6.11 Arla
6.11.1 Arla Company Information
6.11.2 Arla Description and Business Overview
6.11.3 Arla Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Arla Stage 3 Infant Formula Product Portfolio
6.11.5 Arla Recent Developments/Updates
6.12 Holle
6.12.1 Holle Company Information
6.12.2 Holle Description and Business Overview
6.12.3 Holle Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Holle Stage 3 Infant Formula Product Portfolio
6.12.5 Holle Recent Developments/Updates
6.13 Meiji
6.13.1 Meiji Company Information
6.13.2 Meiji Description and Business Overview
6.13.3 Meiji Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Meiji Stage 3 Infant Formula Product Portfolio
6.13.5 Meiji Recent Developments/Updates
6.14 Biostime
6.14.1 Biostime Company Information
6.14.2 Biostime Description and Business Overview
6.14.3 Biostime Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Biostime Stage 3 Infant Formula Product Portfolio
6.14.5 Biostime Recent Developments/Updates
6.15 China Feihe
6.15.1 China Feihe Company Information
6.15.2 China Feihe Description and Business Overview
6.15.3 China Feihe Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.15.4 China Feihe Stage 3 Infant Formula Product Portfolio
6.15.5 China Feihe Recent Developments/Updates
6.16 Junlebao Dairy
6.16.1 Junlebao Dairy Company Information
6.16.2 Junlebao Dairy Description and Business Overview
6.16.3 Junlebao Dairy Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Junlebao Dairy Stage 3 Infant Formula Product Portfolio
6.16.5 Junlebao Dairy Recent Developments/Updates
6.17 Ausnutria Dairy
6.17.1 Ausnutria Dairy Company Information
6.17.2 Ausnutria Dairy Description and Business Overview
6.17.3 Ausnutria Dairy Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Ausnutria Dairy Stage 3 Infant Formula Product Portfolio
6.17.5 Ausnutria Dairy Recent Developments/Updates
6.18 Yili Group
6.18.1 Yili Group Company Information
6.18.2 Yili Group Description and Business Overview
6.18.3 Yili Group Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Yili Group Stage 3 Infant Formula Product Portfolio
6.18.5 Yili Group Recent Developments/Updates
6.19 Synutra
6.19.1 Synutra Company Information
6.19.2 Synutra Description and Business Overview
6.19.3 Synutra Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Synutra Stage 3 Infant Formula Product Portfolio
6.19.5 Synutra Recent Developments/Updates
6.20 Beingmate
6.20.1 Beingmate Company Information
6.20.2 Beingmate Description and Business Overview
6.20.3 Beingmate Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Beingmate Stage 3 Infant Formula Product Portfolio
6.20.5 Beingmate Recent Developments/Updates
6.21 Yashili
6.21.1 Yashili Company Information
6.21.2 Yashili Description and Business Overview
6.21.3 Yashili Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Yashili Stage 3 Infant Formula Product Portfolio
6.21.5 Yashili Recent Developments/Updates
6.22 Bright Dairy
6.22.1 Bright Dairy Company Information
6.22.2 Bright Dairy Description and Business Overview
6.22.3 Bright Dairy Stage 3 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Bright Dairy Stage 3 Infant Formula Product Portfolio
6.22.5 Bright Dairy Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Stage 3 Infant Formula Industry Chain Analysis
7.2 Stage 3 Infant Formula Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Stage 3 Infant Formula Production Mode & Process
7.4 Stage 3 Infant Formula Sales and Marketing
7.4.1 Stage 3 Infant Formula Sales Channels
7.4.2 Stage 3 Infant Formula Distributors
7.5 Stage 3 Infant Formula Customers
8 Stage 3 Infant Formula Market Dynamics
8.1 Stage 3 Infant Formula Industry Trends
8.2 Stage 3 Infant Formula Market Drivers
8.3 Stage 3 Infant Formula Market Challenges
8.4 Stage 3 Infant Formula Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Mead Johnson
Nestle
Danone
Abbott
FrieslandCampina
Heinz
Bellamy
Topfer
HiPP
Perrigo
Arla
Holle
Meiji
Biostime
China Feihe
Junlebao Dairy
Ausnutria Dairy
Yili Group
Synutra
Beingmate
Yashili
Bright Dairy
听
听
*If Applicable.